Is this you? Create Your Porfile
Avatar

Gordon Thomas

Ipsen

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Gordon Thomas is active.

Explore More

Publication

Featured researches published by Gordon Thomas.

Archive | 2000

UTILISATION DE DERIVES D'IMIDAZOPYRAZINES POUR PREPARER UN MEDICAMENT DESTINE A TRAITER LES PATHOLOGIES QUI RESULTENT DE LA FORMATION DE LA PROTEINE G HETEROTRIMETRIQUE

Prevost Gregoire; Lonchampt Marie Odile; Gordon Thomas

Archive | 2010

UTILIZACION DE DERIVADOS DE LA CISTEINA PARA PREPARAR UN MEDICAMENTO DESTINADO A TRATAR LAS PATOLOGIAS RESULTANTES DE LA FORMACION DE LA PROTEINA G HET.

Prevost Gregoire; Lonchampt Marie-Odile; Gordon Thomas

Archive | 2010

ANWENDUNG VON CYSTEIN-DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS BESTIMMT ZUR BEHANDLUNG VON PATHOLOGIEN HERVORGEHEND AUS ENTSTEHUNG DER PROTEIN G HET

Prevost Gregoire; Lonchampt Marie-Odile; Gordon Thomas

Archive | 2007

(1R)-1-[({(2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl]-3-oxopropyl}dithio)methyl]-2-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo [1,2-a]pyrazin-7(8H)-yl]-2-oxoethylamine and pharmaceutically acceptable salt thereof for use in treating cancer

Prevost Gregoire; Diolez Christian; Auguet Michel; Favre Christine; Chabrier De Lassauniere Pierre; Gordon Thomas; Morgan Barry

Archive | 2005

Produkt, der inhiberer signaltransduktion fra heterotrimere G-proteiner, kombineret med et andet cancerbekæmpende middel til terapeutisk anvendelse i cancerbehandlingen

Prevost Gregoire; Morgan Barry; Lonchampt Marie-Odile; Gordon Thomas

Archive | 2005

ZUSAMMENSETZUNG ENTHALTEND EINEN INHIBITOR DER SIGNALTRANSDUKTION VON HETEROTRIMERISCHEN G-PROTEINEN IN KOMBINATION MIT EINEM ANDEREN ANTI-KREBS MITTEL ZU EINER THERAPEUTISCHEN VERWENDUNG IN DER KREBSBEHANDLUNG

Prevost Gregoire; Lonchampt Marie-Odile; Gordon Thomas; Morgan Barry

Archive | 2005

PRODUCTO QUE COMPRENDE UN INHIBIDOR DE LA TRANSDUCCION DE LAS SEÑALES DE LAS PROTEINAS G HETEROTRIMETRICAS EN ASOCIACION CON OTRO AGENTE ANTI-CANCEROSO PARA UNA UTILIZACION TERAPEUTICA EN EL TRATAMIENTO DEL CANCER.

Prevost Gregoire; Lonchampt Marie-Odile; Gordon Thomas; Morgan Barry

Archive | 2003

Pharmaceutical composition of cysteine derivative for treating pathologies which result from the formation of the heterotrimeric G protein

Prevost Gregoire; Lonchampt Marie-Odile; Gordon Thomas

Archive | 2003

COMBINATION OF PRODUCT INHIBITING TRANSDUCTION OF G HETEROTRIMERIC PROTEIN SIGNALS AND ANTI-CANCER AGENT FOR USE IN CANCER TREATMENT

Gordon Thomas; Lonchampt Marie-Odile; Morgan Barry; Prevost Gregoire

Archive | 2003

Product comprising inhibitor of heterotrimeric G protein transduction signals combined with another anticancer agent for therapeutic in cancer treatment

Prevost Gregoire; Lonchampt Marie-Odile; Gordon Thomas; Morgan Barry

Explore More

Collaboration

Dive into the Gordon Thomas's collaboration.

Top Co-Authors
Avatar

Prevost Gregoire

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Lonchampt Marie-Odile

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Auguet Michel

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Chabrier De Lassauniere Pierre

Ipsen

View shared research outputs
Top Co-Authors
Avatar

Favre Christine

Ipsen

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge